KNOBELMAN DEBORAH 4
4 · Kronos Bio, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
KNOBELMAN DEBORAH
President & Interim CEO
Transactions
- Award
Common Stock
2024-06-03+164,260→ 164,260 total - Award
Employee Stock Option (Right to Buy)
2024-06-03+246,390→ 246,390 totalExercise: $0.74Exp: 2034-06-02→ Common Stock (246,390 underlying)
Footnotes (1)
- [F1]25% of the shares shall vest and become exercisable on June 3, 2025 and the remaining shares shall vest in 36 equal monthly installments as of the last calendar day of each month thereafter.